Adapting biomarker technologies to adverse outcome pathways (AOPs) research: current thoughts on using in vivo discovery for developing in vitro target methods

J Breath Res. 2015 Jul 14;9(3):039001. doi: 10.1088/1752-7155/9/3/039001.
No abstract available